Understanding Berkley Insurance Australia’s (BIA) Life Sciences Insurance Policy

Innovation in life sciences doesn’t come without exposure. Whether developing medical devices, pharmaceuticals, or new research technologies, businesses face a unique combination of operational, regulatory, and product‑related risks. BIA’s Life Sciences Insurance Policy is designed to support organisations that participate in this sector including those involved in laboratory work, clinical trials, and product manufacturing and distribution.

Three pillars of this policy stand out for life sciences organisations: Clinical Trials, Products Liability and Public Liability. These coverages are designed to address the core exposures companies may face in their day‑to‑day operations and in the products they bring to market.

Clinical Trial Insurance

Clinical Trials Insurance is an important protection for life sciences organisations conducting human research. It is designed to respond to claims alleging liability to pay compensation for bodily injury, illness, or adverse reactions sustained by study participants as a result of their involvement in a trial.

Why It Matters

Participant‑centred risk: Even well‑designed trials carry inherent uncertainty, and unanticipated reactions can lead to significant liability exposure.

Regulatory mandates: In some jurisdictions, regulations may require sponsors to maintain no‑fault or fault‑based insurance coverage before a trial can begin.

Global trial complexity: Multinational studies introduce varied ethics standards, contractual obligations, and differing legal thresholds, expanding the potential for claims.

Reputational sensitivity: How an organisation responds to participant harm can materially influence trust with regulators, partners, and future trial participants.

For companies advancing new therapeutics, diagnostics, devices, or biologics into human studies, this coverage is designed to complement scientific progress by providing coverage that assists companies in managing the associated legal and financial risks.

Products Liability: Safeguarding Innovation After It Leaves Your Hands

Products Liability is an important protection for life sciences companies. It responds to claims alleging liability to pay compensation for bodily injury, property damage, or medical monitoring expenses caused by a defect or failure in a product after it has been supplied or manufactured.

Why It Matters

Long‑tail exposures: Life sciences products may give rise to claims years after use.

Complex supply chains: Components, manufacturing partners, and trial data multiply the risk points.

Regulatory and consumer expectations: Even minor failures can lead to costly litigation, recalls, or reputational damage.

For companies commercialising advanced therapeutics, diagnostics, medical devices, or supplements, this coverage assists in managing the legal and financial risks associated with innovation.

Public Liability: Protecting Against Real‑World Interactions

Public Liability insurance is designed to respond to claims for liability to pay compensation when third parties allege injury, illness, or property damage arising from the organisation’s premises. In the life sciences sector, where visitors, contractors, trial participants, and suppliers may interact with high‑tech environments and sensitive materials, this coverage is essential.

Why It Matters

High‑risk environments: Laboratories and development facilities present inherent hazards.

Frequent third‑party interaction: Customers, clinical volunteers, suppliers, and researchers depend on safe access.

Rising scrutiny: Regulators in some jurisdictions and partners increasingly demand evidence of robust operational safeguards.

A Combined Risk Solution Built for Life Sciences

BIA’s Life Sciences policy isn’t an off‑the‑shelf liability product – it is tailored for organisations operating in environments where science, patient safety, and regulation intersect. The policy can also integrate (through optional extensions for an additional premium), additional specialised components such as professional indemnity, biological agents liability, product withdrawal expenses and data breach expense coverage.

Final Thoughts

The pace of innovation in life sciences is accelerating, and with it comes corresponding risk. Ensuring purpose‑built liability coverage is important.

BIA’s Life Sciences Insurance Policy delivers this important protection through our purpose-built, scalable insurance offering addressing the emerging issues faced by life sciences companies.

Important Notice

Berkley Insurance Company (limited company incorporated in Delaware, USA) ABN 53 126 559 706 t/as Berkley Insurance Australia is an APRA authorised general insurer. Information provided is general only, intended for brokers and has been prepared without taking into account any person’s particular objectives, financial situation or needs. Insurance cover is subject to terms, conditions, limits, and exclusions. When making a decision to buy or continue to hold a product, you should review the relevant policy documents.